Catalyst
Slingshot members are tracking this event:
Preclinical data released on ARQ 531 Reversible BTK Inhibitor in Ibrutinib Resistant CLL and Richter's Transformation
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ARQL |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 09, 2018
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Cll, Richter's Transformation
